Template:Neuroendocrine tumors: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Overview|Overview]] | [[Neuroendocrine tumors # Overview|Overview]] | ||
|- | |- | ||
! | ! | ||
| Line 22: | Line 22: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Historical perspective|Historical Perspective]] | [[Neuroendocrine tumors# Historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
| Line 28: | Line 28: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Classification|Classification]] | [[Neuroendocrine tumors# Classification|Classification]] | ||
|- | |- | ||
! | ! | ||
| Line 34: | Line 34: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Pathophysiology|Pathophysiology]] | [[Neuroendocrine tumors# Pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
| Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Causes|Causes]] | [[Neuroendocrine tumors# Causes|Causes]] | ||
|- | |- | ||
! | ! | ||
| Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Epidemiology and Demographics|Epidemiology and Demographics]] | [[Neuroendocrine tumors# Epidemiology and Demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Risk Factors|Risk Factors]] | [[Neuroendocrine tumors# Risk Factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
| Line 57: | Line 57: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Natural history, complications and prognosis|Natural History, Complications and Prognosis]] | [[Neuroendocrine tumors# Natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
| Line 63: | Line 63: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#History and symptoms|History and Symptoms]] | [[Neuroendocrine tumors# History and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
| Line 69: | Line 69: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Laboratory findings|Laboratory Findings]] | [[Neuroendocrine tumors# Laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
| Line 75: | Line 75: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#CT|CT]] | [[Neuroendocrine tumors# CT|CT]] | ||
|- | |- | ||
! | ! | ||
| Line 81: | Line 81: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#PET|PET]] | [[Neuroendocrine tumors# PET|PET]] | ||
|- | |- | ||
! | ! | ||
| Line 87: | Line 87: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Medical therapy|Medical Therapy]] | [[Neuroendocrine tumors# Medical therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
| Line 93: | Line 93: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Surgery|Surgery]] | [[Neuroendocrine tumors# Surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||